Hogan Lovells expands Global Regulatory practice with former FDA reviewer
Global law firm Hogan Lovells has added Jemin Dedania to the firm’s Global Regulatory practice as a Director of Regulatory Affairs. In this role, Dedania will assist clients on regulatory and policy issues, with a focus on U.S. Food and Drug Administration (FDA) medical device and combination product strategies.
Dedania advises medical technology companies on matters related to life cycle management, promotional issues, and compliance, and provides general advice on navigating FDA's regulatory framework. He has worked with combination products and medical devices since completing his master's thesis in biomedical engineering, in which he focused on novel growth factor technologies in bone healing.
Upon graduating from the New Jersey Institute of Technology, he was a lead reviewer, and later a team lead at FDA's Center for Devices and Radiological Health in the Division of Orthopedic Devices (now the Office of Health Technology 6) for nearly eight years. He then transitioned to Stryker, where he served developed regulatory strategies for new product development projects, authored regulatory submissions, provided guidance on novel combination product submissions, interfaced with notified bodies, led advertising and promotion reviews, supported mergers and acquisition due diligence and integration efforts, and developed his staff.
Dedania obtained his bachelor's degree in biomedical engineering from the University of Tennessee, his master's degree in the same field from the New Jersey Institute of Technology, and his MBA from Johns Hopkins Carey Business School.